Association between irisin and homocysteine in euglycemic and diabetic subjects

Clinical Biochemistry

Volumn 47, Issue 18, 2014, Pages 333-335

  Alis, Rafael ^a   Sanchis Gomar, Fabian ^b,c   Pareja Galeano, Helios ^b,c   Hernández Mijares, Antonio ^b,c,d,e   Romagnoli, Marco ^a   Víctor, Víctor M ^b,c,d,e   Rocha, Milagros ^c,d,e  

^a UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c Instituto Universitario IVI INCLIVA   (Spain)

^d Service of Digestive Medicine   (Spain)

^e Foundation for the Promotion of Healthcare Biomedical Research in the Valencian Community (FISABIO)   (Spain)

Author keywords

Cardiovascular risk factors; Homocysteine; Irisin; Myokine; Nicotinamide

Indexed keywords

HOMOCYSTEINE; IRISIN; NICOTINAMIDE; UNCLASSIFIED DRUG; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; INSULIN; LIPID;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FIBRONECTINS; HOMOCYSTEINE; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED;

EID: 84921409082     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.08.017     Document Type: Article

References (15)

1. Bostrom P., Wu J., Jedrychowski M.P., Korde A., Ye L., Lo J.C., et al. A pgc1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
2. Spiegelman B.M. Banting lecture 2012: regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes 2013, 62:1774-1782.
3. Sanchis-Gomar F., Perez-Quilis C. Irisinemia: a novel concept to coin in clinical medicine?. Ann Nutr Metab 2013, 63:60-61.
4. Sanchis-Gomar F., Perez-Quilis C. The p38-pgc-1alpha-irisin-betatrophin axis: exploring new pathways in insulin resistance. Adipocyte 2014, 3:67-68.
5. Maron B.A., Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med 2009, 60:39-54.
6. Kuloglu T., Aydin S., Eren M.N., Yilmaz M., Sahin I., Kalayci M., et al. Irisin: a potentially candidate marker for myocardial infarction. Peptides 2014, 55C:85-91.
7. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37(Suppl. 1):S81-S90.
8. Choi Y.K., Kim M.K., Bae K.H., Seo H.A., Jeong J.Y., Lee W.K., et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 2013, 100:96-101.
9. Moreno-Navarrete J.M., Ortega F., Serrano M., Guerra E., Pardo G., Tinahones F., et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013, 98:E769-E778.
10. Ndrepepa G., Kastrati A., Braun S., Koch W., Kolling K., Mehilli J., et al. Circulating homocysteine levels in patients with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008, 18:66-73.
11. Melnyk S., Pogribna M., Pogribny I.P., Yi P., James S.J. Measurement of plasma and intracellular s-adenosylmethionine and s-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5'-phosphate concentrations. Clin Chem 2000, 46:265-272.
12. Canto C., Auwerx J. Nad+ as a signaling molecule modulating metabolism. Cold Spring Harb Symp Quant Biol 2011, 76:291-298.
13. Kraus D., Yang Q., Kong D., Banks A.S., Zhang L., Rodgers J.T., et al. Nicotinamide n-methyltransferase knockdown protects against diet-induced obesity. Nature 2014, 508:258-262.
14. Salek R.M., Maguire M.L., Bentley E., Rubtsov D.V., Hough T., Cheeseman M., et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 2007, 29:99-108.
15. Sanchis-Gomar F., Alis R., Pareja-Galeano H., Sola E., Victor V.M., Rocha M., et al. Circulating irisin levels are not correlated with bmi, age, and other biological parameters in obese and diabetic patients. Endocrine 2014, 46:674-677.